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1. Introduction 
1.1 Context 
Mechanical ventilation is a life-saving procedure used for treating acute respiratory distress, 
when the respiratory system is no longer capable of regulating blood gases via pulmonary 
gas exchange. While conventional mechanical ventilation (CMV) is often sufficient to 
transiently replace lung function until recovery, the most severe respiratory distress 
syndromes must be treated either by non conventional mechanical ventilation such as high 
frequency ventilation or even non ventilator strategies such as extracorporeal gas exchange 
(Raoof et al., 2010). 
Large literature data suggest a radical change in ventilator support by replacing the 
traditional gas mixture with a breathable liquid. This method, called liquid assisted 
ventilation, leads to the replacement of the air-liquid interface in the alveoli by a liquid-
liquid interface. Since the 70s, perfluorocarbon liquids (PFC) have been identified as the best 
candidates to be used in liquid ventilation due to their high oxygen and carbon dioxide 
solubility (Wolfson & Shaffer, 2005). In addition, they are biochemically stable and bio-inert 
molecules, available as medical grade products including for respiratory use. Liquid 
assisted ventilation can be performed either as partial or total liquid ventilation. During 
partial liquid ventilation, only a fraction of the lungs are filled with perfluorocarbon liquid 
and a conventional mechanical gas ventilator ensures lung ventilation. In contrast, during 
total liquid ventilation (TLV), the lungs are completely filled with perfluorocarbon liquid 
while a dedicated device, called a liquid ventilator, must be used to periodically renew a 
liquid tidal volume in the lungs. A large number of preclinical studies involving various 
animal models of acute respiratory distress syndrome have demonstrated clear benefits 
from total liquid ventilation as compared to all other tested ventilation strategies, including 
partial liquid ventilation, conventional and high frequency gas ventilation (Hirschl et al., 
1996; Wolfson et al., 2008). Among its several theoretical advantages over CMV, TLV is 
considered less aggressive for the lungs, due to lower positive inspiratory pressures and 
lower respiratory rates. This is felt to be beneficial in both pediatric and adult respiratory 
distress syndromes, where repeated alveolar overdistension during CMV contributes to 
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acute and chronic lung injury (Chan et al., 2007; Hayes et al., 2010; Speer, 2009). Moreover, it 
offers a new means to clean the lung of inflammatory debris (Richman et al., 1992; Foust et 
al., 1996 Avoine et al., 2011). Consequently, a round table discussion of experts in liquid 
ventilation has unanimously recommended that a liquid ventilator must be developed for 
clinical applications (Costantino et al., 2009). 
1.2 Problem 
In TLV, minute ventilation has been previously reported to be a significant limiting factor 
for gas exchange (Bull et al., 2009; Matsuda et al., 2003), due to choked flows during 
expiration, which severely impede lung emptying and greatly decrease tidal volume (Koen 
et al., 1988; Baba et al., 2004; Robert et al., 2009). Even if the mechanical stresses of the 
collapses on the airway are not significant (Bagnoli et al., 2007), a decrease in minute 
ventilation can affect arterial blood gases. Previously, we have shown that the use of a 
pressure controlled mode prevents choked flows (Robert et al., 2010) and allows maximizing 
Vmin. The location of the pressure sensor in the trachea is motivated by the fact that the 
expiratory collapses can occur in the first airway (Robert et al., 2009) or close to the carina 
(Bull et al., 2005). Hence, the pressure controlled mode maintains a constant acceptable 
negative pressure in the trachea during the expiratory flow, such that the limiting 
phenomena of collapse can be avoided (Robert et al., 2010). It is important to note that such 
control mode is new in TLV because all previously published liquid ventilator prototypes 
were controlled in volume (Baba et al., 1996; Corno et al., 2003; Hirschl et al., 1995; 
Polhmann et al., 2011; Sekins et al., 1999). However, the insertion of a pressure sensor in the 
mouth can be problematic in a clinical context, thus the main issue is to adapt this pressure 
controlled mode without a pressure sensor in the trachea.  
Many efficient demonstrations of TLV have been performed with different prototypes 
(Corno et al. 2003; Cox et al. 2003; Degraeuwe et al., 2000a; Hirschl et al., 1995; Larrabe et al., 
2001; Meinhardt et al., 2000; Parker et al., 2009; Pohlmann et al., 2011; Sekins et al., 1999; 
Tredici et al., 2004). With O2 saturated PFC and limited to low minute ventilations 
(comparatively to CMV), they obtained acceptable ventilation. However, the use of O2 
saturated PFC has never been questioned, despite the fact that high concentrations of O2 in 
the lungs are a well-known factor contributing to acute and chronic lung injury (Hayes et al. 
2010; Speer 2009; Tasake et al., 2008). In addition, the use of O2-saturated PFC during TLV 
often results in hyperoxia. This is particularly deleterious in neonatal medicine in which 
even a transitory hyperoxia can result in so-called neonatal oxygen radical disease. This 
disease affects multiple organs including lung, retina, gut and brain and results in acute and 
chronic morbidities with potential lifelong consequences (Bitterman, 2009; Dorfman et al., 
2010; Gitto et al., 2009). Hence, an efficient liquid ventilator with a pressure regulated mode 
capable of reaching high Vmin must include a device to control the oxygenation. 
1.3 Objective 
For the liquid ventilator prototype to reach the readiness level for clinical applications, the 
objective is dual. From an engineering perspective, it must ensure both targeted minute 
ventilation and oxygenation. From a medical perspective, it must resemble other 
conventional ventilators to be operated by clinicians in intensive care units.  
Consequently, two distinct objectives are targeted: 
i. Implement a pressure regulation mode, but with a pressure sensor located at the mouth 
and not in the trachea. Moreover, the proposition is to translate what has been done in 
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CMV to liquid ventilators: inspiration and expiration should be controlled in pressure 
(Simon et al., 2000). Finally, a control algorithm must prevent large lung volume which 
may compromise the cardiovascular system or induce a perfluorothorax (rupture of the 
lungs). 
ii. Control the O2 concentration in the inspired PFC, similarly to what is done in CMV 
with the control of oxygen concentration in inspired air (FiO2).  
2. Description of Inolivent-4 
2.1 The prototype Inolivent-4 
Following years of research in liquid ventilator development for animal experiments, this 
study presents the most advanced prototype of liquid ventilator, Inolivent-4 (figure 1). Its 
design is based on fundamental concepts developed for our third prototype, Inolivent-3 
(Robert et al., 2006) and by including the most recent knowledge on flow dynamics in liquid 
ventilation (Bossé et al., 2010).  Inolivent-3 comprises two independent piston pumps and an 
oxygenator unit which regroups the heating system, buffer reservoir and condenser (used to 
recuperate the PFC vapors emanating from the oxygenator columns). These concepts have 
demonstrated their efficiency during animal experiments and were maintained for our 
following prototype, Inolivent-4. The latter, compared to its predecessors, includes different 
ventilation control modes like those found on conventional ventilators (Robert et al., 2007b; 
Robert et al., 2010). From a clinician’s point of view, volume controlled ventilation (VCV) 
during inspiration and pressure controlled ventilation (PCV) during expiration, greatly 
simplifies the use of liquid ventilator and minimizes the risk of incorrect ventilation 
parameter selection which could induce systematic airway collapses and lead to oxygen 
deprivation.  
 
Parameter Description Unit 
Fr Respiratory frequency RPM 
Vt Tidal volume ml 
FgasO2 Fraction of oxygen in the gas bubbled % 
Ti Inspiration time s 
Teip End inspiration pause time % 
Teep End expiration pause time % 
Pref,e Expiration reference pressure cmH2O 
Pref,i Inspiration reference pressure  cmH2O 
PLIM,H Upper inspiration limit pressure  cmH2O 
PLIM,L Lower expiration limit pressure  cmH2O 
PEEPref Reference PEEP cmH2O 
Table 1. Ventilation parameters available on the user interface. 
The table 1 presents the basic ventilator parameters accessible on the touch screen user 
interface. A schematic of the ventilator circuit (figure 1) represents the PFC flow path. Its 
operation can be described by considering a typical liquid ventilation cycle. The cycle starts 
when the valve 1 is opened and the valve 2 is closed; a tidal volume of PFC is pumped from 
the buffer reservoir by the inspiration pump. When the inspiratory pump is ready, the valve 
1 is closed, the valve 2 is opened. Then, the inspiratory pump pushes the tidal volume of 
PFC into the lungs. When the active inspiration phase is completed, the valve 2 is closed. 
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The inspiration pause is when both valves 2 and 4 are closed. Valve 4 is then opened and the 
active expiration starts: the expiratory pump removes the tidal volume of PFC from the 
lungs. Finally, the valve 4 is closed to operate the expiration pause. Simultaneously, the 
valve 3 is opened and the expiration pump pushes the PFC inside the filter which goes to 
the oxygenator. By overflow, the oxygenated PFC travels to the buffer reservoir. The time 
parameters (Fr and Ti) and the tidal volume serve as cycle limits. The end inspiration and 
expiration pauses are used to measure the positive-end inspiratory pressure (PEIP) and 
positive-end expiratory pressure (PEEP). The duration is proportional (in percentage) to the 
length of each phase. The upper and lower pressure limits stop the corresponding phase, in 
case the airway pressure goes beyond these values. The reference PEEP is used by the PEEP 
controller to correct the inspired or expired volume (see section PEEP controller).  
 
 
Fig. 1. Picture of Inolivent-4 (left) and the schematic of the ventilator circuit (right).  
The “Y” piece (figure 2) is connected to the endotracheal tube (ET). It includes a mechanical 
3 way valve to select the CMV port, the TLV circuit or the closed position. An airway 
pressure sensor can be located in the ET tube (via an epidural catheter inserted into the Y-
piece) to monitor the tracheal pressure. A pressure sensor located in the Y-piece is used to 
measure the mouth pressure (Py). The new pressure controller regulates Py both during the 
inspiration and expiration phases.  
All actuators and sensors are connected to a real-time control unit composed of a PC with 
two analog input boards (PCI-DAS1602, Measurement Computing, USA) and one analog 
output board (PCI-DAC6703, Measurement Computing, USA). The user interface is a touch 
screen PC which communicates with the real-time control unit.  
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Fig. 2. “Y“-piece connected to the endotracheal tube.  
2.2 Oxygenator description 
Research teams in TLV have mainly used bubble oxygenators (Parker et al., 2009; Sekins et 
al., 1999; Tissier et al., 2009), commercial membrane oxygenators (Corno et al. 2003; Larrabe 
et al., 2001; Hirschl et al., 1995; Wolfson et al., 1999, 2008) or have developed membrane 
oxygenators specifically for TLV (Tredici et al., 2004). However, the requirements for 
extracorporeal blood oxygenation appear irrelevant in TLV, since there is no mechanical 
stress to the blood (hemolysis) or bubble infusion in the blood (Iwahashi et al., 2004). Hence, 
a bubble oxygenator seems acceptable for a clinical use. 
The bubble oxygenator of Inolivent-4 is composed of 2 translucent, polycarbonate cylinders, 
which communicate with each other at the bottom of the inner cylinder (figure 3). When the 
PFC retrieved from the lung is pumped into the inner cylinder, an equivalent volume of PFC 
overflows into the outer cylinder and to the buffer reservoir. In this manner, the PFC coming 
from the lungs is not in direct contact with the PFC going to the lungs. Therefore the PFC 
residence time in the oxygenator is maximized. The gas to be bubbled flows through a 
perforated santopreneTM rubber membrane (McMaster, USA) at the bottom of the 
oxygenator. The latter has approximately 470 perforations made with a 1.2 mm diameter 
needle, (all equally spaced with a rounded pattern over the entire membrane surface) which 
generate bubbles into both cylinders (Beaudry, 2009). The stainless steel base contains three 
100-watt cartridge heaters (Watlow, St-Louis, USA), which maintain the PFC at the targeted 
temperature. A condenser on top of the oxygenator liquefies the PFC vapors to minimize 
evaporative losses.  
2.3 Oxygen concentration control 
To control the O2 concentration in the bubbled gas (FgasO2), medical air is blended with O2 
using a gas mixer system. The latter is composed of two proportional valves (ET-P-10-6025, 
Clippard, USA) controlled by two solenoid drives (B5950, Canfield Connector, USA). Each 
proportional valve controls the air and O2 flow, measured by distinct flowmeter (41211, 
41212, TSI, USA). The reference flow for each bubbled gas is computed based on the 
required FgasO2 and on the total gas flow requested by the user. These references and the 
measured flows are used by two separate feedback controllers (one for both gases), which 
were programmed using Simulink (MathWorks, MA, USA) and implemented with xPC 
target (MathWorks, MA, USA). An O2 gas sensor (KE-25, Figaro, Japan) measures the FgasO2, 
allowing the latter to be modulated from 21% to 100%. Pressure regulators (MMR-1N-P60, 
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Clippard, USA) decrease line pressure while gas filters (C-02917-00, Parker, USA) remove 
unwanted particles, which could impair flowmeter measurements. 
 
 
Fig. 3. Sketch of the oxygenator and the buffer reservoir with PFC flow (left) and without 
PFC flow (right). (1) Gas mixer system with O2 gas sensor to measure FgasO2, (2) gas mixing 
chamber with a rubber membrane to generate bubbles, (3) circuit of the expired PFC with O2 
liquid sensor, (4) circuit of the expired PFC with O2 liquid sensor, (a) when the expired PFC 
is inserted there is an overflow of PFC from the oxygenator to the buffer reservoir, (b) the 
inspired PFC is pumped from the buffer reservoir 
In order to measure oxygen fraction concentration, a fluorescence sensor (Fibox 3 LCD, 
PreSens Precision Sensing GmbH, Germany) was used to determine the O2 fraction in the 
PFC liquid, at the inspiratory (FiPFCO2) and expiratory (FePFCO2) circuit alternately. Data 
were recorded with the software provided by PreSens (LCDPST3 V1.16, PreSens Precision 
Sensing GmbH, Germany). The 90th percentile response time of the sensor is 40 s and was 
measured in-vitro in our laboratory (Beaudry, 2009). 
2.4 The pressure controller 
2.4.1 The targeted pressure 
The pressure controller commands the pumps during the inspiration and expiration to track 
desired pressure (figure 4) measured at the mouth, with the pressure sensor in the “Y-
piece”. 
Before the inspiration, the airway pressure is equal to the PEEP which depends on the end-
expiratory lung volume (VEELV). At the start of the inspiration, the pressure (Py) must 
increase from the PEEP level to the inspiratory reference pressure (Pref,i) in less than 1 
second. The pressure regulator regulates the inspiratory flow to maintain Py within ± 1 
cmH2O of Pref,i. When the tidal volume Vt,i is completely inserted in the lungs or when the 
inspiration time Ti is reached, the inspiration is stopped. During the end inspiratory pause, 
the airway pressure is equal to the PEIP which depends on the end-inspiratory lung volume 
(VEILV).  
At the start of the expiration, Py must decrease from the PEIP to the expiratory reference 
pressure (Pref,e). The pressure regulator controls the expiratory flow which maintains Py 
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within ± 1 cmH2O of (Pref,e). When the tidal volume Vt,e is completely removed from the 
lungs or when the expiratory time Te is reached, the expiration is stopped. During the end-
expiratory pause, the airway pressure must reach the desired PEEP, called PEEPref. If not, 
modifications are done on the volume to be inspired or expired in order to correct the PEEP. 
Those modifications are made by the PEEP follower. 
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Fig. 4. Reference respiratory cycle in pressure regulated mode 
2.4.2 The controller 
Based on the work presented in a previous publication (Robert et al., 2010), the objective is 
to insert or remove the PFC liquid from the lungs at a specified pressure reference, Pref,e 
during expiration phase and Pref,i during inspiration. In control terms, the problem is to 
implement a feedback loop to command the pump, U, as a function of the error between the 
pressure reference, Pref, and the Y pressure Py as illustrated in figure 5.  
The design of the pressure regulator for the inspiration and expiration was done by loop 
shaping, using the robust design toolbox of Matlab (Mathworks, USA). The pressure 
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regulator bandwidths were set at 2 Hz. The controller design follows a pole placement 
procedure where the process plant P(s) with a regulator C(s) leads to an open loop transfer 
function, chosen to be an integrator with a low pass filter at 100 rad/s.  
 
 
Fig. 5. Block diagram of the control system. C: Controller; G: Pump model; F: Tube dynamic; 
H: Lung model; P: Plant. 
The robust control toolbox gave a lag filter coupled with a notch filter. The lag filter cancels 
the pole and zero of the motor, lungs and ET tube. The notch filter compensates for the tube 
resonance. Thus, the form of the controller is; 
   2 22 2 2 22 /11 2 / f fcc f
c f f f f
s c ss
C s K K
s s K d c s K
 
  
             
 (1) 
Where ǃ and τc cancel the pole and zero of the lung, motor and ET tube, Kc is set to achieve 
the desired bandwidth, the gain Kf adjusts the filter gain in higher frequency (2.0), ωf is the 
notch filter frequency (15 rad·s-1), c and d are the filter parameters (5.5). Gain scheduling 
was done in order to take into consideration all the ET tube diameters (from 4 to 6 mm) and 
different fluid properties (PFOB and PFDEC). 
2.5 The PEEP controller 
2.5.1 The specifications 
The PEEP controller acts on the inspiration and expiration tidal volumes from cycle to cycle. 
It monitors the volumes inspired, the volume expired and the pressure measured during the 
end-expiration pause (PEEP). All these measures coupled with the PEEP reference set by the 
clinician (PEEPref), are used by the PEEP controller to adjust from cycle to cycle the volume 
pumped. In the end, the lung volume is corrected and the reference PEEP is tracked. 
It is important to note the difference between the PEEP and the Pref,e. In conventional 
mechanical ventilation, the PEEP set on the user interface is the pressure reference 
maintained in the airway by the pressure regulator. In TLV, the Pref,e is much lower than the 
PEEP in order to maximize the ventilation frequency. Since the PEEP is a clinical setting on 
all mechanical ventilators, a control scheme was developed for the liquid ventilator 
2.5.2 The algorithm 
PEEP regulation can be obtained by controlling the end-expiratory lung volume VEELV with 
a supervisor (Robert et al., 2007a). Cycle after cycle, the balance between inserted and 
retrieved PFC volume can be used to increase or decrease VEELV. The PEEP estimate takes 
into consideration the pumping errors that could occur during the expiration. The PEEP 
controller removes these volume errors from the PEEP measured during the expiratory 
pause (PEEPm), since it is corrected by the supervisor.  
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As in a conventional mechanical ventilator, the clinician specifies a required PEEP (PEEPref). 
This value is compared to the PEEP estimated (PEEPest) during the end-expiratory pause of 
the kth cycle. The step of increasing or decreasing VEELV (the volume correction ΔV) is 
proportional to the PEEP error (limited to avoid too large variations and/or instabilities) 
and expiratory volume error Ee: 
         Δ PEEP est ref eV k K PEEP k PEEP k E k    (2) 
A limit is imposed on the estimated PEEP variation but not on the expiratory volume error. 
The equation 3 is used to estimate the PEEP. 
      eest m
PEEP
E k
PEEP k PEEP k
K
   (3) 
Where KPeep is a gain and Ee[k] is the volume error measured during the expiration. 
Theoretically, the product of lung elastance EL = CL-1 (cmH2O·ml-1) and expiratory volume 
error Ee provides an exact estimate of the PEEP. However, for improved robustness, KPeep 
was fixed. If the volume correction is negative, the volume to be inspired for the next cycle 
(Vt,i[k+1]) is lower than the tidal volume Vt  in order to increase the lung volume 
    ,
                          0
1          0
t
t i
t
V if V
V k
V V k if V
       
 (4) 
If the volume correction is positive, the volume to be expired for the next cycle is lower than 
the tidal volume Vt in order to decrease the lung volume 
       ,
1                          0
1
1         0
t i
t e
t i
V E k if V
V k
V E k V k if V
            
 (5) 
Where Ei[k+1] is the inspiratory volume error for the [k+1]th cycle. 
3. Validation of the oxygenator 
3.1 Oxygenator time-constant measurement 
The oxygenator is modeled as a first order system characterized by a time constant, τ. To 
measure the oxygenator time constant, the method consisted to perform a step time test: 
FPFCO2(t) was recorded when the oxygen concentration in the bubbled gas is abruptly 
switched from FgasO2(t)=0 for t≤0 to FgasO2(t)=100% for t>0, at null initial condition 
(FPFCO2(0)=0%). To generate this system excitation, pure CO2 was first bubbled in order to 
retrieve all dissolved O2 from the PFC. Once PPFCO2 reached less than 5 mmHg, the gas 
brought under the membrane was switched to pure O2 at a fixed flow rate. The PPFCO2 was 
recorded at a sampling time of 1 second (figure 6 presents a typical measured time response) 
to compute off-line the FPFCO2.  
The data was fed to the System Identification Toolbox of Matlab (Mathworks, USA) to 
identify the time constant values (by selecting a first order linear system) and its 95% 
confidence interval. The procedure was repeated for different oxygen flows by using 
incremental values of 0.5, 1, 2, 4, 6 and 8 L/min at a PFC temperature of 39ºC. As can be 
www.intechopen.com
 Progress in Molecular and Environmental Bioengineering  
– From Analysis and Modeling to Technology Applications 
 
332 
seen in the table 2, the smallest time constant was 14 seconds at an O2 flow of 8 L/min. 
Thus, in the worst case scenario when there is no oxygen in the PFC, the concentration 
reaches 95% of the FgasO2 after 42 seconds. Fortunately, this case will not happen, since the 
expired PFC will always contain a certain amount of oxygen. A theoretical development can 
mathematically quantify this fact with the index  . 
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Fig. 6. Typical O2 partial pressure variation measured in the PFC versus time at a flow rate 
of 6 l/min. 
 
O2 flow (L/min) τ (s)   (%)  
0.5 167 38 
1 77 58 
2 41 73 
4 22 85 
6 17  89  
8 14 91 
Table 2. Identified time constants (in seconds) for different O2 flow rates (L/min) at 39°C. 
The 95% confidence interval was equal or inferior to 1 second for all values. The  values are 
computed with equation (9) for tc=10s and ǂ=10%. 
3.2 An index to evaluate the oxygenator efficiency 
To quantify oxygenator efficiency throughout all of the experiments, the following index is 
computed: 
    2 2 2 2/PFC PFC gas PFCFi O Fe O F O Fe O     (6) 
An   equal to 0 signifies an inefficient oxygenator since FiPFCO2 = FePFCO2. Conversely, an 
  equal to 1 signifies a perfect oxygenator since FiPFCO2 = FgasO2. 
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Considering the dynamic response of the oxygenator as a first order system, it is possible to 
write the index of efficiency (6) as a function of the time constant and the ventilator 
parameters. In the following demonstration, the initial time refers to the instant when the 
tidal volume Vt is expired from the lungs and mixed with the PFC volume already present 
in the oxygenator. Considering the oxygenator as a first order system characterized by a 
time constant, τ, the initial oxygen concentration is assumed equal to the expired PFC mixed 
proportionally with the PFC volume in the oxygenator. Thus, 
      2 2 20     1PFC PFC PFCF O ǂFe O ǂ Fi O  (7) 
where a=Vt/V0 is the volume ratio, V0 is the PFC oxygenator volume and the PFC tidal 
volume, Vt. The final cycle time, t=tc, is when a Vt goes through the oxygenator to the buffer 
reservoir by overflow (when the tidal volume of PFC expired from the lungs is pushed into 
the oxygenator). Since the PFC in the buffer reservoir will be pumped to the lungs during 
the next cycle, the inspired oxygen concentration FiPFCO2=FPFCO2(tc). Considering these 
assumptions, it is obvious that: 
  2 2 21PFC gas PFCFi O F O Fe O     (8) 
Where the index defined by (6) is: 
 

 
      
1 exp( )
1 exp (1 )
c
c
t
t
a
 (9) 
An   equal to 0 occurs if the cycle time tc is much smaller than the time constant (tc/τ→ 0). 
On the other hand, an   equal to 1 signifies a perfect oxygenator since FiPFCO2=FgasO2. This 
case occurs if the tidal volume is smaller than the oxygenator volume (Vt/V0→0). Finally, an 
  superior to 90% indicates that the oxygenator is almost independent of expired PFC gas 
concentration since the contribution of FePFCO2 to FiPFCO2 is inferior to 10%. 
3.3 In-vivo validation of the oxygenator  
3.3.1 In-vivo protocol 
The experimental protocol was approved by our institutional Ethics Committee for Animal 
Care and Experimentation. For the in vivo protocol, five healthy newborn lambs (<4 days 
old, 2.5-3.6 kg) were intubated, anaesthetized and paralyzed as detailed previously (Robert 
et al., 2010). The lambs were premedicated by intramuscular injection, orally intubated with 
a 5.0 or 5.5 mm cuffed endotracheal tube (Mallinckrodt, St. Louis, MO) and restrained in 
supine position under radiant heat to maintain a central temperature of 39±1°C. The lambs 
were ventilated with a conventional mechanical ventilator (Servo 300 ventilator, Siemens-
Elema AB, Solna, Sweden) in pressure-regulated, volume controlled mode (positive end-
expiratory pressure (PEEP) = 4 cmH2O, Vt = 10 ml/kg, FiO2 = 100%, respiratory frequency 
(Fr) = 50 breaths/minute, inspiratory time on expiratory time ratio (I:E) = 1:2). The baseline 
parameters were recorded after 30 minutes. Inolivent-4 was then used to initiate and 
perform TLV. Lungs were first filled (25 ml/kg) with warmed (39.0 ± 0.5ºC) and pre-
oxygenated perfluorodecalin with a PEEP of 7 cmH2O. TLV was then initiated (Fr = 
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5.35/minute, Vt = 20 ml/kg, I:E = 1:3, FgasO2 = 100%) (Robert et al. 2010). Fifteen minutes 
after reaching each new setting, the PFC partial pressure of oxygen, PPFCO2, was measured 
with the liquid sensor (Fibox 3 LCD, PreSens, Germany) in both the expired (PePFCO2) and 
inspired (PiPFCO2) PFC. An arterial blood sample was also drawn for PaO2 and PaCO2 
measurements. 
Three different settings were tested using the following parameters. First a reduction in 
minute ventilation (Vmin) from 180 to 120 ml/min/kg at an FgasO2 = 100% and constant gas 
flow of 6 l/min. Second, a reduction in gas flow from 8 to 0.5 l/min at an FgasO2 = 100% and 
constant Vmin = 180 ml/min/kg. Finally, a reduction in FgasO2 from 100 to 65% at constant 
gas flow of 8 l/min and Vmin = 180 ml/min/kg. 
Prior to each experiment, the maximum O2 partial pressure value in the PFC, PPFCO2,100%, 
was noted in order to calculate both the O2 concentration in the inspired PFC 
(FiPFCO2=PiPFCO2/PPFCO2,100%) and the O2 concentration in the expired PFC 
(FePFCO2=PePFCO2/PPFCO2,100%). This value was obtained by bubbling pure O2 in the 
oxygenator, during the TLV preparation phase (which is a closed-loop circulation of the PFC 
in the liquid ventilator). After 10 minutes, the measured O2 partial pressure in the PFC was 
invariant and close to the atmospheric pressure. This measured value was noted as 
PPFCO2,100%. The atmospheric pressure was measured with a precision dial barometer (4199, 
Control Company, USA).  
Statistical values were obtained with the Statistics Toolbox provided with Matlab 
(Mathworks, USA). Statistical significance was assumed at p < 0.05. The Shapiro-Wilk test 
was first applied to each group to verify sample normality. The paired Student-t test was 
used to test a significant difference between two paired groups, after verification that 
homoscedacity was respected with the two samples F-test. The relationship between PaO2 
and FiPFCO2 was established by using linear regression statistics (Seber, 1989) in order to 
compute the regression coefficients R2. An F-test was finally performed on the slope.  
3.3.2 In-vivo results 
Upon transfer from conventional gas ventilation (Vmin =602 ± 50 ml/min/kg; FiO2=100%) to 
total liquid ventilation (Vmin=180 ± 3 ml/min/kg; FgasO2=100%), blood gases were not 
significantly different (CMV: PaO2=285 ± 87 mmHg, PaCO2=39 ± 3 mmHg, pH=7.35 ± 0.05; 
TLV: PaO2 = 217 ± 76 mmHg, PaCO2=43 ± 5 mmHg, pH=7.25 ± 0.07). 
Decreasing pure O2 flow from 8 to 4 l/min (table 3) did not lead to a significant decrease in 
FiPFCO2 and FePFCO2, the oxygenator efficiency index remaining in the range 80 to 73%. On 
the contrary, a significant decrease in FiPFCO2 was observed for O2 flow below 4 l/min. 
Despite this decrease in FiPFCO2, no significant decrease in PaO2 was observed for all O2 
flows tested and PaO2 was maintained above 100 mmHg. Meanwhile, PaCO2 and pH were 
significantly altered for pure O2 flow at 0.5 l/min. Finally, the oxygenator efficiency index 
dramatically dropped at 54% for O2 flow at 0.5 l/min, showing the inability of the 
oxygenator to saturate the PFC with O2 at this flow level. 
When FgasO2 was reduced from 100 to 65% (table 4), FiPFCO2 decreased from 96 to 64% and 
FePFCO2 decreased from 80% to 31%. Between each decrement of FgasO2, significant 
differences were observed both in FiPFCO2 and FePFCO2, although no significant differences 
were observed in oxygenator efficiency, which remained in the range of 96 to 80%. No 
significant differences were observed for either PaCO2 or pH with the various FgasO2 tested. 
As expected, PaO2 simultaneously decreased from 217 to 99 mmHg, a significant correlation 
being observed between PaO2 and FiPFCO2 (and the oxygenator efficiency index) in the 5 
newborn lambs tested (Slope = 350 mmHg with R2=0.37, Fisher test p<0.05). 
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 O2 gas flow (l/min) 
 8 6 4 2 11 0.51 
FiPFCO2 (%) 96±1 96±1 95±2 94±1 93±2 88±2 
FePFCO2 (%) 80±2 80±2 80±3 78±3 77±3 74±4 
  (%)  80±7 77±4 77±9 73±7 69±7 54±7 
PaO2 (mmHg) 217±76 234±64 213±57 232±54 188±59 177±412 
PaCO2 (mmHg) 43±5 41±3 44±5 47±4 50±6 60±10 
pH 7.25±0.07 7.28±0.05 7.26±0.06 7.26±0.05 7.22±0.06 7.14±0.06 
Table 3. In vivo results obtained in 5 newborn lambs while varying gas flow and 
maintaining FgasO2 at 100% and Vmin=180 ml/min/kg. Data are presented as mean ± SD with 
underbraces indicating statistical significance (p<0.05). FiPFCO2, oxygen fraction of inspired 
PFC; FePFCO2, oxygen fraction of expired PFC; , oxygenator efficiency index; PaO2, partial 
pressure of oxygen in arterial blood; PaCO2, partial pressure of CO2 in arterial blood; pH, 
arterial blood pH. 1Data obtained with 4 lambs. 2Measurements did not pass the Shapiro-
Wilk normality test and were excluded from the significance test 
 FgasO2 (%) 
 100 90 80 751 701 651 
FiPFCO2 (%) 96 ± 1 89 ± 2 78 ± 1 74 ± 1 69 ± 1 64 ± 1 
FePFCO2 (%) 80 ± 2 72 ± 5 61 ± 3 57 ± 3 52 ± 2 46 ± 4 
  (%) 80 ± 7 96 ± 13 91 ± 7 93 ± 5 95 ± 5 95 ± 4 
PaO2 (mmHg) 217 ± 76 153 ± 53 133 ± 63 149 ± 53 100 ± 39 99 ± 47 
PaCO2 (mmHg) 43 ± 5 45 ± 6 44 ± 32 43 ± 4 44 ± 5 45 ± 3 
pH 7.25±0.07 7.23±0.07 7.25±0.05 7.25±0.06 7.26±0.06 7.25±0.06 
Table 4. In vivo results obtained in 5 newborn lambs while varying FgasO2 at a constant gas 
flow of 8 l/min and Vmin =180 ml/min/kg. Data are presented as mean ± SD with 
underbraces indicating statistical significance (p<0.05). Vmin, minute ventilation; FiPFCO2, 
oxygen fraction of inspired PFC; FePFCO2, oxygen fraction of expired PFC; ǂ, oxygenator 
efficiency index; PaO2, Partial pressure of oxygen in arterial blood; PaCO2, Partial pressure 
of CO2 in arterial blood; pH, arterial blood pH. 1Data obtained with 4 lambs. 2Measurements 
did not pass the Shapiro-Wilk normality test and were excluded from the significance test. 
3.4 Discussion regarding the oxygenator 
Results in the present and previous (Avoine et al., 2011; Beaudry 2009; Robert et al. 2010) 
studies show that our custom-designed bubble oxygenator can oxygenate PFC at a level up 
to FiPFCO2=96%, which is similar to previously published data obtained with a silicone 
hollow fiber membrane oxygenator in rabbits (93%, when considering a standard 
atmospheric pressure of 760 mmHg) (Tredici et al., 2004) or commercial membrane 
oxygenator (84%) (Cox et al., 2003; Stavis et al., 1998). In addition, the maximal PaO2 of 234 
mmHg obtained herein is similar to the PaO2 value of 201 mmHg previously reported in 
healthy newborn lambs by others (Hirschl et al., 1995; Larrabe et al., 2001; Stavis et al., 1998, 
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Cox et al. 2003). Beyond their low cost and simplicity of use, the present study clearly shows 
that bubble oxygenators can be highly efficient during TLV. 
Our results highlight elevated PaO2 values, which can be obtained in TLV in the presence of 
an O2-saturated PFC, when minute ventilation is maximized. The present results show that 
it is possible to control PaO2 during total liquid ventilation without altering alveolar 
ventilation or oxygenator efficiency. The PaO2 can be controlled by adjusting the O2 fraction 
in the gas flowing into the oxygenator, thus mimicking the method used in conventional gas 
ventilation. Reduction of gas flow to the oxygenator decreases the oxygenator efficiency 
index, with the most undesirable effect being the deterioration of the CO2 removal before 
any effect on PaO2 reduction. Similar results, on the high flow rate requirement in order to 
achieve an efficient CO2 removal, were previously reported with a hollow-fiber oxygenator 
in a rabbit model (Tredici et al., 2004). 
Finally, as expected, our method based on the control of FgasO2 with a gas mixer enabled us 
to adjust FiPFCO2 and consequently to control PaO2 down to safer values without 
significantly altering PaCO2 and pH. The use of this particular method, which reproduces 
the manner in which FiO2 is controlled in all existing conventional gas ventilators, has never 
been reported for TLV. 
This study could be deemed as being limited to a specific PFC, a perfluorodecalin (PFDEC), 
since another PFC, the perfluoroctylbromide (PFOB), is usually considered as the PFC of 
choice for TLV. It was used in clinical studies I/II on partial liquid ventilation (Kacmarek et 
al., 2006; Hirschl et al., 1998, 2002). However, the conclusions should be the same, regardless 
of the PFC type, since the oxygenator is able to control the gas concentration, reach the 
desired oxygen fraction in the inspired PFC (FiPFCO2) and remove the CO2. 
4. Validation of the pressure controller 
4.1 In-vivo protocol 
The experimentations were obtained with 10 healthy anaesthetized and paralyzed newborn 
lambs (age < 5 days, weight < 4 kg, 1 hours TLV trial with PFOB or PFDEC). The 
experimental protocol was approved by our institutional Ethics Committee for Animal Care 
and Experimentation. The lamb was placed in a supine position and an epidural catheter 
was inserted in the Y-piece such that the extremity extended 1 centimeter before the ET tube 
ending. The other end of the catheter was connected to a pressure sensor located at the same 
height as the ET tube in the trachea. The pressure sensor (Model 1620, Measurement 
Specialties, Hampton, VA) was used to measure airway pressure Paw in the trachea. 
After randomization, the lungs were filled at functional residual capacity (25 ml/kg) with 
warmed and oxygenated PFDEC or PFOB. After PFC instillation, total liquid ventilation was 
initiated in volume-controlled mode (during the first minute) at a rate of 5.35 
breaths/minute and a Vt = 40 ml with an FgasO2 of 100%. Then, the ventilation modes were 
switched rapidly to pressure regulated modes for both inspiration and expiration and the 
pressure references Pref,i and Pref,e were adjusted to reach the desired tidal volume (25 ml/kg) 
at a frequency around 6.4 rpm.  
4.2 In-vivo results 
Figure 7 presents typical results for the pressure regulators during TLV using PFDEC and 
PFOB. The controllers were able to reach the pressure references, without oscillations. The 
airway pressure Paw was much lower that the Y pressure Py during the inspiration, since the 
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ET tube added a significant pressure loss in the fluid circuit. Those losses were highly 
influenced by the inside diameters of the ET tube (considered in the design of the 
controllers).  
There was no airway collapse during the expiration even if the airway pressure was below 
−10 cmH2O. The airway pressure decreased proportionally during the expiration. This can 
be explained as the pressure losses in the ET tube decrease with the flow which in turn, 
decreases exponentially with time, thus resulting in a proportional decrease of the airway 
pressure over time. The pressure references used during TLV with the PFOB are lower, 
because the PFOB viscosity is lower compared to the PFDEC, which affects directly the ET 
tube pressure losses. 
The measured PEEP offset can be explained by looking closely at the volumes pumped in 
the lungs. With PFDEC, the requested tidal volume Vt was 2.5 ml/kg over the volume 
inspired Vt,i. This difference was directly reflected on the expiration volume error Ee (2.43 ± 
0.69 ml/kg). The figure 8 presents typical results for the Peep controller during TLV using 
PFDEC and PFOB. For both PFC the PEEPest was near the PEEPref. There was a slight offset 
since the gain KPeep used was not equal to the dynamic compliance measured. The table 5 
indicates that the mean error between the PEEPref and the PEEPest was around 0.3 ± 
0.1 cmH2O (PFDEC) and 0.4 ± 0.1 cmH2O (PFOB). The measured PEEP was 2.7 ± 0.7 cmH2O 
over the reference for the PFDEC and 1.4 ± 1.1 cmH2O for the PFOB, once the ventilation 
parameters were stabilized. For both PFC, the PEEP controller was stable.  
Using equation 3, it becomes obvious that an error on the expired volume will cause a PEEP 
offset. Since the PFOB is less viscous, it is easier to reach the requested tidal volume Vt. In 
consequence, the expiration error and the PEEP offset are smaller. 
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Fig. 7. Left graphic: Airway pressure (Paw) and Y pressure (Py) versus time for 
Pref,i = 135 cmH2O and Pref,e = -37 cmH2O using PFDEC. Right graphic: Airway pressure (Paw) 
and Y pressure (Py) versus time for Pref,i = 90 cmH2O and Pref,e = -28 cmH2O using PFOB 
The table 5 presents the numerical results obtained on 5 newborn lambs (< 4 days old) per 
PFC group (PFOB and PFDEC). The inspired and expired volume for both groups were 
similar, but the frequency reached using PFOB was higher, even if the pressure reference 
and PEEP measured were lower. Again, the viscosity of the PFDEC is the explanation 
behind these observations. Adequate gas exchange and normal acid-base equilibrium were 
maintained during TLV. 
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Fig. 8. Left top graphic: typical evolution of the PEEP measured (PEEPm), estimated (PEEPest) 
and reference (PEEPref) over a complete experiment with PFDEC. Left bottom graphic: 
typical evolution of the inspired (Vt,i) and expired volume (Vt,e) versus the tidal volume (Vt) 
for PFDEC. Right top graphic: typical evolution of the PEEP measured (PEEPm), estimated 
(PEEPest) and reference (PEEPref) over a complete experiment with PFOB. Right bottom 
graphic: typical evolution of the inspired (Vt,i) and expired volume (Vt,e) versus the tidal 
volume (Vt) for PFOB. References are shown in bold for the PEEPref and Vt. 
 
 PFDEC PFOB 
Vt (ml/kg) 26.9 ± 0.6 25.9 ± 0.9 
Vt,i (ml/kg) 24.4 ± 0.7 24.9 ± 0.4 
Vt,e (ml/kg) 24.6 ± 0.6 25.2 ± 0.4 
Ei (ml/kg) -0.14 ± 0.51 -0.41 ± 0.05 
Ee (ml/kg) 2.43 ± 0.69 1.07 ± 1.00 
Pref,i (cmH2O) 152.7 ± 46.3 111.5 ± 17.3 
Pref,e (cmH2O) -39.1 ± 8.02 -32.9 ± 5.6 
Fr (rpm) 6.14 ± 0.13 6.43 ± 0.08 
Vmin (ml/min/kg) 149.7 ± 5.9 160.3 ± 3.3 
PEEPref (cmH2O) 1.8 ± 0.6 1.0 ± 0.1 
PEEPest (cmH2O) 2.1 ± 0.7 1.3 ± 0.2 
PEEPm (cmH2O) 4.5 ± 1.0 2.3 ± 1.1 
PaO2 (mmHg) 285.0 ± 67.0 288.3 ± 91.4 
PaCO2 (mmHg) 52.9 ± 10.9 37.2 ± 10.2 
pH 7.29 ± 0.11 7.39 ± 0.11 
FgasO2 1.0 ± 0.0 1.0 ± 0.0 
Table 5. Results of 5 healthy newborn lambs for each TLV group (< 4 days old). (mean ± 
standard deviation) 
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4.3 Discussion regarding the PEEP-controller 
The proposed PEEP controller manages directly the end-expiratory alveolar pressure (by 
controlling the PEEP) and all the measurable volume errors. However, all measurable 
volume errors do not include sensor non-linearities, machining tolerances and analog input 
precisions, so the lung volume can derive positively or negatively, if and only if such 
volume derivatives have no impact on the alveolar pressure. In the normal case, the control 
of the end-expiratory alveolar-pressure is equivalent to the control of the end-expiratory 
lung volume (EELV) because there is a direct relationship between these two variables 
(Degraeuwe et al., 2000b; Parker et al., 2009).  
5. Conclusion 
The oxygenator presented at the beginning of this chapter shows that we can control the 
oxygen fraction of the inspired PFC and removal of all the CO2 contained in the expired 
liquid. This control of the oxygen concentration, FiPFCO2, permits the adjustment of the 
arterial partial pressure of oxygen PaO2 without any consequence on the arterial partial 
pressure of CO2, PaCO2. A decrease in the oxygen flow rate through the oxygenator is not a 
suitable solution, since they it compromises the PaCO2, before any effect on PaO2 reduction. 
The choice of a bubble oxygenator could be seen as a limitation, since most research groups 
use membrane oxygenators with TLV (Corno et al. 2003; Cox et al. 2003; Hirschl et al., 1995; 
Larrabe et al., 2001; Parker et al., 2009; Pohlmann et al., 2011; Tredici et al., 2004). On the 
contrary, we strongly believe that bubble oxygenators are quite suitable for TLV. Beyond 
their low cost and simplicity of use, the present study shows that they can be highly efficient 
during TLV.  
The presented pressure controlled ventilation modes seem similar to those used in 
conventional gas ventilators, although there are some differences. The PEEP follower 
maintains the end-expiratory alveolar pressure constant by commanding volume corrections 
based on the end-expiratory pressure. The pressure references Pref,i and Pref,e are higher 
compared to CMV. The pressure controlled mode eliminates the airway collapses and favors 
higher minute ventilation. Thus, it can be implemented successfully on liquid ventilators 
during the inspiration and expiration phases. When used in conjunction with the 
oxygenator presented, the arterial blood gases can be maintained in a normal range 
throughout the liquid ventilation. As for the PEEP controller, the latter compensates all the 
volume errors (measurable and non-measurable) from cycle to cycle, which secures the TLV 
by avoiding lung overdistension.  
There is still room for improvement, as the observed results do not fully comply with the 
defined specifications. The PEEP controller is able to estimate quite well the real PEEP, but 
the measured PEEP can increase since the expired volume is not reached. Modifications will 
be performed to improve PEEP tracking. In some ventilation cycles, the volume expired is 
not achieved. Thus, the pressure limit Pref,e could be adapted from cycle to cycle to increase 
the expired volume. Nevertheless, the pressure regulators and PEEP controller have greatly 
improved the ventilation efficiency and simplified the interaction with the liquid ventilator, 
since all the volumes and errors are managed by controllers from cycle to cycle.  
In the ultimate objective of transferring liquid ventilators into intensive care units 
(Costantino et al., 2009), we strongly recommend the addition of a gas mixer to the 
oxygenator (to adjust the O2 concentration) coupled with pressure controlled ventilation 
mode as two efficient means to maintain normal blood gases during TLV.  
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